Ads
related to: pancreatic cancer, cancer treatment- Dosing & Administration
Find Important Dosing, Modification
& Administration Info for Providers
- Clinical Efficacy, Safety
See Efficacy Results & Study Info
for This Treatment Option
- Resources For Oncologists
Download Dosing Guide, Watch Videos
and More for Providers
- Read The Patient Brochure
Help Patients Take An Active Role
During Treatment. Download & Share.
- Contact a Specialist
HCPs: Get In Touch with an Oncology
Account Specialist for More Info
- Prescribing Information
Provider Info for a Metastatic
Pancreatic Cancer Treatment Option
- Dosing & Administration
Search results
Pancreatic cancer: Some signs that cancer has spread
Medical News Today· 5 days agoWhen pancreatic cancer spreads to other areas of the body, a person may experience new symptoms that are not directly linked to the tumors in the...
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 2 days agoVerastem Oncology reported positive initial results from an ongoing Phase I/II trial investigating...
...Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) at American...
FOX 23 News Albany· 2 days agoThe CheMo4METPANC trial is evaluating the company's CXCR4 inhibitor motixafortide, the PD-1...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 2 days agoFN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention ...
For most, pancreatic cancer is a deadly diagnosis. How one Fort Worth man beat the odds
Fort Worth Star-Telegram McClatchy via AOL· 6 days ago“Where we are now for pancreatic cancer is where we were for colon cancer maybe 40 years ago,”...
BioLineRx reports positive pancreatic cancer trial results By Investing.com
Investing.com· 2 days agoBioLineRx Ltd. (NASDAQ: BLRX), a biopharmaceutical company, announced encouraging results from the...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF ...
WKRN Nashville· 6 days agoFood and Drug Administration (FDA) has granted Orphan Drug Designation to Cantex' azeliragon, a well-tolerated once-a-day pill, for the treatment of pancreatic< ...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga via AOL· 2 days agoThe initial interim results will be presented at the upcoming American Society of Clinical Oncology...
The Big Idea: NYU pioneers non-invasive cancer treatment with histotripsy
FOX 5 New York· 4 days agoNYU is transforming cancer treatment with histotripsy, a non-invasive method using focused...
Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?
Medscape· 6 days agoIn February, the US Food and Drug Administration approved irinotecan liposome (Onivyde) as part of a...